Circular 16 of 2025: PUBLICATION OF SUMMARISED PUBLIC ASSESSMENT REPORTS FOR CLINICAL TRIAL APPLICATIONS AND PUBLIC INSPECTION REPORTS FOR GOOD CLINICAL TRIAL PRACTICE (GCP) INSPECTIONS

Circular 15 of 2025-Notification for Publication of Public Inspection Reports

Circular 14 of 2025-DECLARATION REQUIREMENT FOR DIRECTORS AS A CONDITION OF LICENSURE

Circular 13 of 2025-Deposits into MCAZ Bank Accounts

Circular 12 of 2025 – Fees Schedule

CIRCULAR 10 OF 2025-CLASS II RECALL UP TO RETAIL LEVEL OF TORRENT CAPTOPRIL 25MG TABLETS, REG. NO.: 2000/12.3.5/3685, BATCH: B520K001, MANUFACTURED BY TORRENT PHARMACEUTICALS LTD, INDRAD PLANT, NEAR INDRAD VILLAGE, TALUKA KADI, DISTRICT MEHSANA, GUJARAT, INDIA

CIRCULAR 9 of 2025/Publication-Of-Cancelled-Wholesale-Dealer’s-Permits-Pharmacy-Licence-And-Persons’-Licences

Circular 8 of 2025 – Call For Submission of Applications for Registration Of Human Allopathic Medicines Through the Expedited Review Pathway: Phase I of 2025

Circular 7 of 2025 – Call For Submission Of Applications For Registration Through The Expedited Review Pathway For Veterinary Medicinal Products: PHASE I

Circular 6 of 2025_ Clarification on the sale and distribution of unapproved pharmacopeial and galenical preparations